General Information
Drug ID
DR01425
Drug Name
Ramosetron
Synonyms
132036-88-5; UNII-7ZRO0SC54Y; Ramosetron [INN]; 7ZRO0SC54Y; CHEMBL1643895; Ramosetron (INN); (1-methylindol-3-yl)-[(5R)-4,5,6,7-tetrahydro-3H-benzimidazol-5-yl]methanone; Nor-YM 060; SCHEMBL16701; GTPL2301; DTXSID0043842; NTHPAPBPFQJABD-LLVKDONJSA-N; MolPort-019-991-383; CHEBI:135156; ZINC5116719; AC1L3355; BDBM50334454; 8235AH; AKOS015896003; SB19072; DB09290; SC-92398; AJ-53160; LS-187182; TL8000762; R-146; FT-0651831; D08466; A806353; (-)-(R)-1-Methylindol-3-yl-4,5,6,7-tetrahydro-5-benzimidazolyl ketone; Nasea (TN); YM060
Drug Type
Small molecular drug
Indication Irritable bowel syndrome [ICD11: DD91.0] Approved [1]
Structure
3D MOL 2D MOL
Formula
C17H17N3O
Canonical SMILES
CN1C=C(C2=CC=CC=C21)C(=O)C3CCC4=C(C3)NC=N4
InChI
InChI=1S/C17H17N3O/c1-20-9-13(12-4-2-3-5-16(12)20)17(21)11-6-7-14-15(8-11)19-10-18-14/h2-5,9-11H,6-8H2,1H3,(H,18,19)/t11-/m1/s1
InChIKey
NTHPAPBPFQJABD-LLVKDONJSA-N
CAS Number
CAS 132907-72-3
Pharmaceutical Properties Molecular Weight 279.34 Topological Polar Surface Area 50.7
Heavy Atom Count 21 Rotatable Bond Count 2
Hydrogen Bond Donor Count 1 Hydrogen Bond Acceptor Count 2
XLogP
2.2
PubChem CID
108000
PubChem SID
14824418 , 14848693 , 44436913 , 49830772 , 50070718 , 50112691 , 71879502 , 79053930 , 96025152 , 104380246 , 124974479 , 125084556 , 128751655 , 131297527 , 135141836 , 135650885 , 137446772 , 140430812 , 152035422 , 172659137 , 179149824 , 184546127 , 198983023 , 223562331 , 224977577 , 226406853 , 241031501 , 251912291 , 251916599
ChEBI ID
CHEBI:135156
TTD Drug ID
D0RA9E
DT(s) Transporting This Drug P-GP Transporter Info P-glycoprotein 1 Substrate [2]
References
1 National Center for Advancing Translational Science-Inxight: drug (7ZRO0SC54Y)
2 Contribution of P-glycoprotein to efflux of ramosetron, a 5-HT3 receptor antagonist, across the blood-brain barrier. J Pharm Pharmacol. 2002 Aug;54(8):1055-63.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.